MedPath

Redpharm Drug, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

681

FDA:681

Drug Approvals

Metronidazole

Approval Date
Apr 9, 2025
FDA

OXYCODONE AND ACETAMINOPHEN

Approval Date
Feb 21, 2024
FDA

Dexamethasone

Approval Date
Feb 14, 2024
FDA

Cephalexin

Approval Date
Feb 13, 2024
FDA

Sulfamethoxazole and Trimethoprim

Approval Date
Jan 15, 2024
FDA

oxycodone hydrochloride

Approval Date
Jan 15, 2024
FDA

OXYCODONE AND ACETAMINOPHEN

Approval Date
Nov 28, 2023
FDA

OXYCODONE AND ACETAMINOPHEN

Approval Date
Nov 21, 2023
FDA

HYDROCODONE BITARTRATE AND ACETAMINOPHEN

Approval Date
Nov 21, 2023
FDA

Methocarbamol

Approval Date
Nov 10, 2023
FDA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 69
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.